Proteomics & Protein Research News on protein analysis, clinical proteomics, biomarkers in genetics, genomics, and molecular diagnostics. Oct 4, 2022 Personalis, Duke University, Olink Collaborate on Immunotherapy Markers in Gastric Cancer Sep 21, 2022 Propath UK, Nucleai Partner on Spatial Proteomics Panel for Immuno-Oncology Sep 20, 2022 ImmunoScape Raises $14M Jun 28, 2022 Akoya Biosciences, Acrivon Therapeutics Partner to Develop CDx Jun 28, 2022 QIMR Berghofer Licenses Esophageal Cancer Blood Biomarkers to Proteomics International Jun 13, 2022 OncoHost Licenses SomaLogic Platform to Develop Tests to Predict Patient Response to Immunotherapies Jun 2, 2022 InterVenn BioSciences Hits Commercial Phase, Launches Test for Immunotherapy Response in Melanoma Premium Mar 28, 2022 Theralink Using Phosphoproteomics to Guide Treatment in Late-Stage Breast Cancer Premium Mar 21, 2022 SomaLogic to Process 30K Samples for European Cancer Study Jan 19, 2022 Protein-Based Liquid Biopsy Panel Assesses Tumor Microenvironment, Shows Prognostic Potential Premium Jan 5, 2022 Aspira Women's Health Preliminary Q4 OVA1 Sales up 23 Percent; Firm Details Pipeline Progess Dec 13, 2021 Akoya Biosciences, PathAI Collaborating on Predictive Biomarkers for Cancer Immunotherapies Dec 13, 2021 OncoHost, Heidelberg University Hospital Strike Lung Cancer Biomarker Alliance Oct 29, 2021 Berg Exploring Commercialization Paths for Predictive Pancreatic Cancer Liquid Biopsy Test Premium Oct 26, 2021 Indivumed, Biognosys Expand Partnership to Offer Immunopeptidomics Insights Sep 20, 2021 OncoHost Further Assessing Protein Signature for Predicting NSCLC Patients' Immunotherapy Response Premium Aug 2, 2021 InterVenn Biosciences Closes $201M Series C Round Jul 7, 2021 Fred Hutch Team Develops Mass Spec Assay for HER2 Scoring Premium Jun 4, 2021 Advances in the Search for Proteomic Biomarkers in Immuno-oncology: Highlights from AACR and ASCO May 7, 2021 Proteona Driving Adoption of Immune Profiling Platform for CAR-T, Multiple Myeloma Research Premium Load More Breaking News Apollomics Completes SPAC Merger, Begins Public Trading on Nasdaq Ablaze Pharmaceuticals to Develop RayzeBio's GPC3-Targeted Radiotherapy In Brief This Week: Allarity Therapeutics, Immutep, Thermo Fisher Scientific EMA's CHMP Recommends BMS's Breyanzi as Second-Line Lymphoma Treatment Exai Bio, Quantum Leap Healthcare Collaborative Expand Participation in RNA Liquid Biopsy Trial Omega Therapeutics, Roche Partner for Phase I/II Trial in MYC-Driven Hepatocellular Carcinoma
